Mogens Tornby Stender

Mogens Tornby Stender is a Clinical Associate Professor at Aalborg University's Department of Clinical Medicine (Gastrointestinal Surgery) affiliated with Aalborg University Hospital. He specializes in gastrointestinal oncology and minimally invasive therapeutic approaches, focusing on pancreatic and colorectal cancers. His work integrates surgical techniques like irreversible electroporation with immunotherapy and chemotherapy.

Research interests include pancreatic adenocarcinoma treatment optimization, liver metastasis management, and improving survival outcomes through innovative ablative therapies. He leads or collaborates on five major projects including CHEMOFIRE-2 (2019-2024), exploring combination therapies for pancreatic cancer, and EPIC-1 (2021-2024), investigating electroporation-potentiated immunotherapy for liver metastases.

Publications emphasize surgical safety (e.g., peptic ulcer embolization studies), immunotherapy advancements, and nationwide database analyses of cancer treatment efficacy. His projects often involve multidisciplinary teams addressing unmet clinical needs in gastrointestinal oncology.